Sorry, no content matched your criteria.
Featured Story
This Small-Cap Stock Has Made Us 208% (and It Could Give Us 440% More)
The big caps like Apple and Google are terrific performers, don't get me wrong, but they just can't hold a candle to small-cap gains.
I love small caps because they offer the potential for runaway, triple-digit profits that you can bank as the companies you've picked grow... and grow some more.
These kinds of gains aren't random. They're triggered by "sparks," catalysts that I watch for that can propel stocks upward.
In the case of the biotech stock I'm about to show you, there were a whopping five sparks present.
And, even better, there's likely almost 440% more in gains left for the taking...
The big caps like Apple and Google are terrific performers, don't get me wrong, but they just can't hold a candle to small-cap gains.
I love small caps because they offer the potential for runaway, triple-digit profits that you can bank as the companies you've picked grow... and grow some more.
These kinds of gains aren't random. They're triggered by "sparks," catalysts that I watch for that can propel stocks upward.
In the case of the biotech stock I'm about to show you, there were a whopping five sparks present.
And, even better, there's likely almost 440% more in gains left for the taking...